NCT05365750View on ClinicalTrials.gov

COVID-19 Antibody and Reinfection Study

CompletedOBSERVATIONAL
Enrollment

4,235

Participants

Timeline

Start Date

June 15, 2020

Primary Completion Date

March 30, 2023

Study Completion Date

December 31, 2024

Conditions
COVID-19 Testing
Trial Locations (1)

80014

Kaiser Permanente, Aurora

All Listed Sponsors
lead

Kaiser Permanente

OTHER

NCT05365750 - COVID-19 Antibody and Reinfection Study | Biotech Hunter | Biotech Hunter